Skip to main content
XPOF
NYSE Trade & Services

XPOF Q3 Revenue Falls 21% to $62.3M; Studio-Openings Outlook Cut, EBITDA Guidance Narrowed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Travel & Leisure Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$4.05
Mkt Cap
$217.681M
52W Low
$3.565
52W High
$9.25
52W Position info
14% above low
Off High info
56% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

XPOF is trading near its 52-week low of $3.565 (14% above the low).

Summary

Xponential reported Q3 revenue of $62.3 million, down 21%, and Adjusted EBITDA of $24.3 million, down 27%, while cutting its 2026 studio-opening outlook and narrowing EBITDA guidance. The board's strategic alternatives review, including a possible sale, remains active.


Key Events · Earnings and Guidance · XPOF

  • Q3 Revenue Down 21%

    Total revenue was $62.3 million versus $78.8 million a year earlier, with franchise revenue down 16% to $43.4 million and equipment revenue down 42% to $4.3 million.

  • Profit Shrinks, GAAP Turns Positive

    Adjusted EBITDA fell 27% to $24.3 million from $33.5 million, and adjusted net income was $2.2 million, or $0.04 per basic share, versus $19.3 million, or $0.36. GAAP net income was $4.9 million, or $0.10 per basic share, against a $6.7 million loss a year ago.

  • Studio Growth Outlook Cut

    Full-year 2026 net new studio openings are now guided to 124-130, a 37% decline at the midpoint, versus prior guidance of approximately 150. Adjusted EBITDA guidance narrowed to $91.0-94.0 million from $91.0-97.0 million.

  • Leverage and Cash Burn

    The company held $27.2 million of cash, cash equivalents and restricted cash against $521.1 million of total long-term debt, and used $21.1 million of cash in operating activities over the first nine months of 2026.


Analysis · XPOF · Trade & Services

The profit base is shrinking even as the top line contracts: revenue dropped 21% to $62.3 million and Adjusted EBITDA fell 27% to $24.3 million. Management cut its full-year net new studio openings to 124-130 from roughly 150 and narrowed Adjusted EBITDA to $91.0-94.0 million from $91.0-97.0 million, signaling to franchisees and investors that unit growth is slowing, not just revenue per unit. The balance sheet is the pressure point: $27.2 million of cash against $521.1 million of long-term debt, with $21.1 million of cash burned in the first nine months. Against that backdrop, the board's strategic alternatives review, run with Jefferies and explicitly including a possible sale or merger, is the live variable — and it sits alongside activist Fund 1 Investments' non-binding $5.61-$7.00 per share take-private proposal from October 30 and the 19.9% poison pill adopted October 13.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XPOF was trading at $4.05 on NYSE in the Trade & Services sector, with a market capitalization of approximately $217.7M. The 52-week trading range was $3.57 to $9.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XPOF - Latest Insights

XPOF
Nov 09, 2026, 4:43 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.74
Real-time Price: $4.22 info
Change: -$0.520 (-11%) info
Market Cap: $179.117M info
XPOF
Nov 05, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.42
Real-time Price: $4.22 info
Change: -$0.200 (-5%) info
Market Cap: $179.117M info
XPOF
Oct 30, 2026, 4:22 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $4.48
Real-time Price: $4.22 info
Change: -$0.260 (-6%) info
Market Cap: $179.117M info
XPOF
Oct 20, 2026, 6:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.39
Real-time Price: $4.22 info
Change: -$0.170 (-4%) info
Market Cap: $179.117M info
XPOF
Oct 13, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.94
Real-time Price: $4.22 info
Change: -$0.720 (-15%) info
Market Cap: $179.117M info